Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1998
10/15/1998CA2286305A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
10/15/1998CA2286303A1 20 human secreted proteins
10/15/1998CA2286294A1 Stabilized human papillomavirus formulations
10/15/1998CA2286291A1 Compounds and methods for inhibiting the interaction between a-catenin and b-catenin
10/15/1998CA2286283A1 Human gtp binding protein
10/15/1998CA2286264A1 Insulin-like growth factor agonist peptides
10/15/1998CA2286008A1 Anti-peptide antibody against human cytochrome p450 3a4
10/15/1998CA2285707A1 A sunflower albumin 5' regulatory region for the modification of plant seed lipid composition
10/15/1998CA2285605A1 Fanconi-gene ii
10/15/1998CA2285020A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor
10/15/1998CA2284833A1 Non human transgenic animal in which the expression of the gene coding for insulin is deleted
10/15/1998CA2232861A1 Cdna clone hacch94 that encodes a novel human 7-transmembrane receptor
10/14/1998EP0870839A1 Method for gene introduction into target cells by retrovirus
10/14/1998EP0870831A1 Histidine kinase polypeptides
10/14/1998EP0870830A2 Chimera hepatitis C virus antigen
10/14/1998EP0870829A2 Staphylococcus aureus cell division gene Div1B
10/14/1998EP0870828A1 NOVEL POLYPEPTIDE ORIGINATING IN $i(HEMOPHILUS PARAGALLINARUM) AND PROCESS FOR PRODUCING THE SAME
10/14/1998EP0870827A2 Tumor necrosis factor related receptor, TR6
10/14/1998EP0870508A1 Influenza vaccine
10/14/1998EP0870199A1 Assays for growth hormone secretagogue receptors
10/14/1998EP0870198A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
10/14/1998EP0870058A1 Molecular sequence of swine retrovirus and methods of use
10/14/1998EP0870050A2 Toxic-protein expressing viruses and producer cell lines
10/14/1998EP0870049A2 Complementary adenoviral vector systems and cell lines
10/14/1998EP0870047A2 Episomal vector and uses thereof
10/14/1998EP0870046A1 Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis
10/14/1998EP0870044A1 Regulated protein expression in stably transfected mammalian cells
10/14/1998EP0870043A1 Enhancer-increased gene expression in plants
10/14/1998EP0870042A1 Improved methods for transforming phaffia strains, transformed phaffia strains so obtained and recombinant dna in said methods
10/14/1998EP0870041A2 KVLQT1 - A LONG QT SYNDROME GENE WHICH ENCODES KVLQT1 WHICH COASSEMBLES WITH minK TO FORM CARDIAC I Ks? POTASSIUM CHANNELS
10/14/1998EP0870040A2 Gene delivery vehicle-targeting ligands
10/14/1998EP0870039A1 Recombinant fusion proteins to growth hormone and serum albumin
10/14/1998EP0870032A2 Novel polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy
10/14/1998EP0870031A1 Antimicrobial proteins
10/14/1998EP0870030A1 Polypeptides with interleukin 16 activity, process for the preparation and use thereof
10/14/1998EP0870029A1 Multimer forms of interleukin-16 (il-16), process for the preparation and use thereof
10/14/1998EP0870028A1 Nucleic acids encoding interferon gamma inducing factor-2
10/14/1998EP0870027A1 Novel c-mpl receptor agonists
10/14/1998EP0870026A1 Ob protein derivatives having prolonged half-life
10/14/1998EP0870025A1 Reagents and methods useful for detecting diseases of the breast
10/14/1998EP0870024A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/14/1998EP0870023A1 Osteoprotegerin
10/14/1998EP0870022A1 Immunostimulatory composition and method
10/14/1998EP0870021A1 Novel polynucleotides panc1a and panc1b associated with pancreatic cancer
10/14/1998EP0870020A2 Ligand polypeptides for the g-protein-coupled receptor protein, their production and use
10/14/1998EP0870019A2 Cell activation process and reagents therefor
10/14/1998EP0870018A1 Antitumour vector constructs and methods
10/14/1998EP0870011A1 Salmonella vaccines
10/14/1998EP0869976A1 Design of hormone-like antibodies with agonistic and antagonistic functions
10/14/1998EP0869975A1 Assay for and uses of peptide hormone receptor ligands
10/14/1998EP0869974A1 Compounds with growth hormone releasing properties
10/14/1998EP0869973A2 Mammalian chemokine ccf8 and chemokine receptor cckr3
10/14/1998EP0869972A1 Chemokine from niddm pancreas
10/14/1998EP0869971A1 Two component signal transducing system protein from staphylococcus aureus
10/14/1998EP0869970A1 Endothelial cell proliferation inhibitor and method of use
10/14/1998EP0869805A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications
10/14/1998EP0869802A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions
10/14/1998EP0869707A1 High-affinity potassium uptake transporter from higher plants
10/14/1998EP0764273B1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
10/14/1998EP0687271B1 Extraction of cell-bound protein from bordetella
10/14/1998EP0673388B1 Double chain peptide compounds having hemoregulatory activity
10/14/1998EP0665887B1 Human 5-ht 2? receptor
10/14/1998EP0628054B1 Car receptors and related molecules and methods
10/14/1998EP0446273B1 Monoclonal antibodies to feline-t-lymphotropic lentivirus
10/14/1998CN1196089A DNA polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis
10/14/1998CN1196087A Novel protein HMW human MP52
10/14/1998CN1196086A Enamel matrix related polypeptide
10/14/1998CN1196061A Insulin derivatives
10/14/1998CN1195995A Transcytosis vehicles and enhancers for drug delivery
10/14/1998CN1195982A Fgfr 3 as marker for mesenchymal skelftal progenitor cells
10/14/1998CN1195667A Novel antibody, renin-active substance containing same and prorenin assay reagent using the same
10/14/1998CN1040212C Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions
10/14/1998CN1040178C Complement inhibitor for preparing drug for promoting transplantation survival or eliminating rejection
10/13/1998US5821353 DNA encoding 1,3 beta-D glucan synthase subunits
10/13/1998US5821351 Chimeric human globin gene
10/13/1998US5821341 Antibodies to sICAM-1
10/13/1998US5821339 Compositions and methods for treatment of herpesvirus infections
10/13/1998US5821338 Antibodies specific for OVCA DNA encoded proteins and methods for their use
10/13/1998US5821337 Immunoglobulin variants
10/13/1998US5821336 Polypeptide having specified amino acid sequence or fragment thereof
10/13/1998US5821333 Method for making heteromultimeric polypeptides
10/13/1998US5821332 Isolated receptor polypeptide having specified amino acid sequence; modulating immune response
10/13/1998US5821329 Cyclic peptide inhibitors of β1 and β2 integrin-mediated adhesion
10/13/1998US5821328 Genetic markers for breast, ovarian, and prostatic cancer
10/13/1998US5821238 Administering to patient to impair tumor growth
10/13/1998US5821231 Treatment of immunoinflammatory conditions
10/13/1998US5821225 Substituted at position 22-31 of amino acid sequence of a peptide of parathyroid hormone or parathyroid hormone related peptide
10/13/1998US5821224 Purified beta-defensin with consensus sequence having net positive charge that lacks three consecutive basic amino acids at the carboxyl terminus; polyclonal and monoclonal antibodies and drugs
10/13/1998US5821223 Plasminogen-like growth factor
10/13/1998US5821220 Method of producing concentrated non-buffered solutions of fibronectin
10/13/1998US5821219 Opioid antagonists and methods of their use
10/13/1998US5821218 Regeneration of kidney tissue and use of autocrine growth factors
10/13/1998US5821125 Monoclonal antibody specific for novel PKA binding proteins
10/13/1998US5821124 Hybridoma cell lines and antibodies that bind noggin
10/13/1998US5821123 Modified antibody variable domains
10/13/1998US5821122 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
10/13/1998US5821107 Contacting nematode cyclophilin-like protein with test compound, measuring effects on peptidyl-prolyl cis-trans isomerase activity
10/13/1998US5821094 S-locus receptor kinase gene in a self-incompatible brassica napus line
10/13/1998US5821091 Method of identifying activated T-cells
10/13/1998US5821089 Contacting prokaryotic or eukaryotic cell with growth medium containing trans-4-hydroxyproline or 3-hydroxyproline to incorporate analog into polypeptide produced by cell